论文部分内容阅读
目的:探讨垂体后叶素用于治疗剖宫产产后出血的临床效果。方法:选取近年来于我院行剖宫产术的产妇为研究对象,将其中具有出血指征的产妇796例分为对照组和观察组各398例。对照组产妇采取使用催产素进行治疗,观察组产妇使用垂体后叶素进行治疗,观察分析2组产妇的产后出血治疗效果。结果:观察组产妇术中出血量和术后出血量均明显少于对照组;观察组产后出血发生率为4.8%,低于对照组21.1%;均具有显著差异(P<0.05)。结论:采取垂体后叶素用于治疗剖宫产产后出血治疗疗效显著,能够改善产妇产后出血情况,防止产后大出血的发生。
Objective: To investigate the clinical effect of pituitrin for treating postpartum hemorrhage after cesarean section. Methods: Selecting maternal women who underwent cesarean section in our hospital in recent years as the research object, 796 maternal women with bleeding indication were divided into control group and observation group with 398 cases each. The control group of mothers to take the use of oxytocin for treatment, the observation group of maternal pituitrin treatment, observation and analysis of two groups of postpartum hemorrhage treatment effect. Results: The bleeding volume and postoperative bleeding in the observation group were significantly less than those in the control group. The incidence of postpartum hemorrhage in the observation group was 4.8%, which was lower than 21.1% in the control group (P <0.05). Conclusion: The use of pituitrin for the treatment of postpartum hemorrhage after cesarean section treatment has a significant effect, can improve maternal postpartum hemorrhage and prevent the occurrence of postpartum hemorrhage.